公司资料
Evolent Health 股价、新闻与催化剂
- 股票代码:
- EVH
- 交易所:
- NYSE
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
3.39 USD (-2.87%)
收盘价
最后更新: 2026年10月1日
445M USD
市值
股价为何变动
截至 2026年10月1日，EVH 下跌 2.87%，收于 $3.39。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
Specialty Care Management Company
Evolent Health helps health plans and risk-bearing providers manage care for people with complex conditions. Its programs are designed to improve clinical outcomes while lowering medical expense in high-cost specialty categories.
Oncology and Complex-Care Solutions
The company provides specialty management capabilities in oncology and other areas such as cardiology and musculoskeletal care. Services include evidence-based treatment pathways, utilization management, provider engagement, and care coordination.
Performance-Based Contracting
Evolent uses multi-year contracts that can include administrative fees, risk-sharing, or total-cost-of-care arrangements. This model aligns part of the company's economics with medical-cost and quality outcomes achieved for clients.
Technology and AI-Enabled Operations
Clinical data, workflow software, analytics, and AI-enabled operating tools support authorization decisions, member identification, provider communication, and program measurement. The platform is designed to integrate with payer and provider systems rather than replace them.
未来催化剂
近期新闻
新闻标题由机器翻译，详情为英文原文。
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。